About: BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-based neurobehavioural testing. Its smartphone-based application serves as a device for conducting neurobehavioral evaluations and objective sensorimotor biomarkers, which provides scientific support for future regulatory approval and clinical adoption. The company's application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Perth, Australia.
Sector: Healthcare
Industry: Health Information Services
Latest price: A$0.65 (-1.52%)
BB1 ASX Blinklab Ltd
Blinklab Ltd share price
BB1 price activity
Último preço
$ 0,650
Variação (24h)
-0,01 AUD (-1,52%)
Volume
58.74K
Volume (média 4 sem.)
-
Abertura
$ 0,65
Variação do dia
$ 0,64 - $ 0,66
Fechamento anterior
$ 0,66
Último negócio
07 Oct, 5:10 am GMT+0
Atrasado
07 Oct, 5:10 am GMT+0
BB1 price performance
Atrasado
07 Oct, 5:10 am GMT+0
quote.marketSignals